发明名称 Immunoassay for thrombin detection
摘要 The invention relates to an in vitro immunoassay for quantifying thrombin in a sample comprising anti-thrombin III (AT-III) and thrombin. The method comprises the following steps: contacting the sample with a small molecule that recognizes the substrate binding site of thrombin; contacting the thrombin with a thrombin specific antibody raised against a thrombin blocked in the active site; and measuring the level of bound antibody.
申请公布号 US9329183(B2) 申请公布日期 2016.05.03
申请号 US201514710097 申请日期 2015.05.12
申请人 Omrix Biopharmaceuticals Ltd. 发明人 Nur Israel;Orr Nadav;Mintz Roni
分类号 G01N33/573;G01N33/86;C07K16/36 主分类号 G01N33/573
代理机构 代理人 Crichton David R.
主权项 1. An in vitro immunoassay for quantifying thrombin in a sample in the presence of anti-thrombin III (AT-III), the immunoassay comprising the steps of: contacting the sample with a small molecule that recognizes a substrate binding site of thrombin and is selected from the group consisting of naturally occurring hirudin, synthetic hirudin variants, hirudin derivatives, recombinant hirudin variants, hirudin mimics, and a combination thereof; adding to the sample mixture a thrombin specific antibody, wherein the thrombin specific antibody consists of a polyclonal antibody or a fragment thereof and was raised against a thrombin having a blocked active site with a molecule selected from the group consisting of Phe-Pro-Arg-chloromethylketone (PPACK), 4-aminophenylpyruvic acid (APPA), 4-(2-aminoethyl)benzenesulfonyl fluoride (AEBSF), and a combination thereof; measuring the binding of the polyclonal antibody or fragment thereof to thrombin in the sample mixture; and quantifying the amount of thrombin by comparison and extrapolation from a predetermined thrombin standard curve using known amounts of purified thrombin.
地址 Rehovot IL